Dehydroepiandrosterone stimulates the estrogen response element

Journal of Steroid Biochemistry and Molecular Biology

Volumn 62, Issue 5-6, 1997, Pages 461-466

  Bruder, Jan M ^a   Sobek, Lothar ^b   Oettel, Michael ^b  

^a Univ of Texas Health Science Center ^*  (United States)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; LUCIFERASE; PRASTERONE; STEROID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN ACTIVITY; HORMONAL REGULATION; HORMONE ACTION; MOUSE; NONHUMAN;

ANDROSTENEDIONE; ANIMALS; AROMATASE INHIBITORS; CELL LINE; DEHYDROEPIANDROSTERONE; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; GENES, REPORTER; GENETIC VECTORS; HUMANS; LUCIFERASES; MICE; RECEPTORS, ESTROGEN; TRANSFECTION;

EID: 0031465938     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00056-3     Document Type: Article

References (22)

1. Meikle A. W., Dorchuck R. W., Araneo B. A., Stringham J. D., Evans T. G., Spruance S. L. and Daynes R. D., The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. Journal of Steroid Biochemistry and Molecular Biology 42 (1992) 293-304.
2. Okabe T., Haji M., Takayanagi R., Adachi M., Imasaki K., Kurimoto F., Watanabe T. and Nawata H., Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. Journal of Clinical and Endocrinology and Metabolism 80 (1995) 2993-2996.
3. Gronemeyer H., Transcription activation by estrogen and progesterone receptors. Annual Review of Genetics 25 (1991) 89-123.
4. Gronemeyer H., Control of transcription activation by steroid hormone receptors. FASEB Journal 6 (1992) 2524-2528.
5. Yamamoto K. R., Steroid receptor regulated transcription of specific genes and gene networks. Annual Review of Genetics 19 (1985) 209-252.
6. Kreitmann B. and Bayard F., Androgen interaction with the oestrogen receptor in human tissues. Journal of Steroid Biochemistry 11 (1979) 1589-1595.
7. 5 androstene-3β, 17β-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. Journal of Clinical Endocrinology and Metabolism 40 (1975) 373-379.
8. Adams J., Garcia M. and Rochefort H., Estrogenic effects of physiological concentrations of 5-androstene-3β, 17-diol and its metabolism in MCF-7 human breast cancer cells. Cancer Research 41 (1981) 4720-4726.
9. Price T., Aitken J. and Simpson E. R., Relative expression of aromatase cytochrome P450 in juman fetal tissues as determined by competitive polymerase chain reaction amplification. Journal of Clinical Endocrinology and Metabolism 74 (1992) 879-883.
10. Thomas M. L., Xu X., Norfleet A. M. and Watson C. S., The presence of functional estrogen receptors in intestinal epithelial cells. Endocrinology 132 (1993) 426-430.
11. Kepa J. K., Neeley C. I., Jacobsen B. M., Bruder J. M., McDonnell D. P., Leslie K. K. and Wierman M. E., Estrogen receptor mediated repression of rat gonadotropin releasing hormone (GnRH) promoter activity in hypothalamic cells. Endocrine 2 (1994) 947-956.
12. Kepa J. K., Jacobsen B. M., Boen E. A., Pendergast P., Edwards D. P., Takimoto G. and Wierman M. E., Direct binding of progesterone receptor to nonconsensus DNA sequences represses rat GnRH. Molecular and Cellular Endocrinology 117 (1996) 27-39.
13. Brodie A. M. H., Schwarzel W. C., Shaikh A. A. and Brodie H. J., The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Endocrinology 100 (1977) 1684-1695.
14. Wakeling A. E., Dukes M. and Bowler J., A potent specific pure antiestrogen with clinical potential. Cancer Research 51 (1991) 3867-3873.
15. Meyer T., Koop R., von Angerer E., Schonenberger H. and Holler E., A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. Journal of Cancer Research and Clinical Oncology 120 (1994) 359-364.
16. Tora L., Mullick A., Metzger D., Panglikitmongkol M., Park I. and Chambon P., The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO Journal 8 (1989) 1981-1986.
17. Mellon P. L., Windle J. J., Goldsmith P. C., Padula C. A., Roberts J. L. and Weiner R. I., Neuron 5 (1990) 1-10.
18. Bruder J. M. and Wierman M. E., Evidence for transcriptional inhibition of GnRH gene expression by phorbol ester at a proximal promoter region. Molecular and Cellular Endocrinology 99 (1994) 177-182.
19. Labrie F., Belanger A., Simard J., Luu-The V. and Labrie C., DHEA and peripheral androgen and estrogen formation: intracrinology. Annals of the New York Academy of Science 774 (1995) 16-28.
20. Ebling P. and Koivisto V. A., Physiological importance of dehydroepiandrosterone. Lancet 343 (1994) 1479-1481.
21. Hornsby P. J., Current challenges for DHEA research. Annals of the New York Academy of Science 774 (1995) 13-14.
22. Dunn J. F., Nisula B. C. and Rodbard D., Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism 53 (1981) 58-68.